790 related articles for article (PubMed ID: 11751416)
61. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
Piatelli MJ; Doughty C; Chiles TC
J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
[TBL] [Abstract][Full Text] [Related]
62. Functional roles of Akt signaling in mouse skin tumorigenesis.
Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
[TBL] [Abstract][Full Text] [Related]
63. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway.
Mazzoni IE; Saïd FA; Aloyz R; Miller FD; Kaplan D
J Neurosci; 1999 Nov; 19(22):9716-27. PubMed ID: 10559381
[TBL] [Abstract][Full Text] [Related]
64. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the phosphatidylinositol 3-kinase-Akt pathway.
Sakata K; Kato S; Fox JC; Shigemori M; Morimatsu M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):975-83. PubMed ID: 12430714
[TBL] [Abstract][Full Text] [Related]
65. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
[TBL] [Abstract][Full Text] [Related]
66. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
[TBL] [Abstract][Full Text] [Related]
67. Grb-2-associated binder-1 is involved in insulin-induced egr-1 gene expression through its phosphatidylinositol 3'-kinase binding site.
Harada S; Esch GL; Holgado-Madruga M; Wong AJ
DNA Cell Biol; 2001 Apr; 20(4):223-9. PubMed ID: 11403719
[TBL] [Abstract][Full Text] [Related]
68. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Kim IA; Bae SS; Fernandes A; Wu J; Muschel RJ; McKenna WG; Birnbaum MJ; Bernhard EJ
Cancer Res; 2005 Sep; 65(17):7902-10. PubMed ID: 16140961
[TBL] [Abstract][Full Text] [Related]
69. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells.
Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F
Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531
[TBL] [Abstract][Full Text] [Related]
70. ERK activation and mitogenesis in human airway smooth muscle cells.
Lee JH; Johnson PR; Roth M; Hunt NH; Black JL
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1019-29. PubMed ID: 11290527
[TBL] [Abstract][Full Text] [Related]
71. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways.
Barnabé-Heider F; Miller FD
J Neurosci; 2003 Jun; 23(12):5149-60. PubMed ID: 12832539
[TBL] [Abstract][Full Text] [Related]
72. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
73. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.
Amin MA; Volpert OV; Woods JM; Kumar P; Harlow LA; Koch AE
Circ Res; 2003 Aug; 93(4):321-9. PubMed ID: 12881477
[TBL] [Abstract][Full Text] [Related]
74. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
[TBL] [Abstract][Full Text] [Related]
75. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival.
Vaillant AR; Mazzoni I; Tudan C; Boudreau M; Kaplan DR; Miller FD
J Cell Biol; 1999 Sep; 146(5):955-66. PubMed ID: 10477751
[TBL] [Abstract][Full Text] [Related]
76. Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling.
Liu Y; Hiraiwa Y; Liu E; Kurata H; Thant AA; Matsuda S; Hamaguchi M
Oncogene; 2001 Sep; 20(41):5908-12. PubMed ID: 11593397
[TBL] [Abstract][Full Text] [Related]
77. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
78. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
[TBL] [Abstract][Full Text] [Related]
79. Short-term delay of Fas-stimulated apoptosis by GM-CSF as a result of temporary suppression of FADD recruitment in neutrophils: evidence implicating phosphatidylinositol 3-kinase and MEK1-ERK1/2 pathways downstream of classical protein kinase C.
Kotone-Miyahara Y; Yamashita K; Lee KK; Yonehara S; Uchiyama T; Sasada M; Takahashi A
J Leukoc Biol; 2004 Nov; 76(5):1047-56. PubMed ID: 15328334
[TBL] [Abstract][Full Text] [Related]
80. Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.
Lentzsch S; Gries M; Janz M; Bargou R; Dörken B; Mapara MY
Blood; 2003 May; 101(9):3568-73. PubMed ID: 12506012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
